192 related articles for article (PubMed ID: 10958653)
1. Myotilin is mutated in limb girdle muscular dystrophy 1A.
Hauser MA; Horrigan SK; Salmikangas P; Torian UM; Viles KD; Dancel R; Tim RW; Taivainen A; Bartoloni L; Gilchrist JM; Stajich JM; Gaskell PC; Gilbert JR; Vance JM; Pericak-Vance MA; Carpen O; Westbrook CA; Speer MC
Hum Mol Genet; 2000 Sep; 9(14):2141-7. PubMed ID: 10958653
[TBL] [Abstract][Full Text] [Related]
2. Myotilin, a novel sarcomeric protein with two Ig-like domains, is encoded by a candidate gene for limb-girdle muscular dystrophy.
Salmikangas P; Mykkänen OM; Grönholm M; Heiska L; Kere J; Carpén O
Hum Mol Genet; 1999 Jul; 8(7):1329-36. PubMed ID: 10369880
[TBL] [Abstract][Full Text] [Related]
3. myotilin Mutation found in second pedigree with LGMD1A.
Hauser MA; Conde CB; Kowaljow V; Zeppa G; Taratuto AL; Torian UM; Vance J; Pericak-Vance MA; Speer MC; Rosa AL
Am J Hum Genet; 2002 Dec; 71(6):1428-32. PubMed ID: 12428213
[TBL] [Abstract][Full Text] [Related]
4. Defective myotilin homodimerization caused by a novel mutation in MYOT exon 9 in the first Japanese limb girdle muscular dystrophy 1A patient.
Shalaby S; Mitsuhashi H; Matsuda C; Minami N; Noguchi S; Nonaka I; Nishino I; Hayashi YK
J Neuropathol Exp Neurol; 2009 Jun; 68(6):701-7. PubMed ID: 19458539
[TBL] [Abstract][Full Text] [Related]
5. Myotilin, the limb-girdle muscular dystrophy 1A (LGMD1A) protein, cross-links actin filaments and controls sarcomere assembly.
Salmikangas P; van der Ven PF; Lalowski M; Taivainen A; Zhao F; Suila H; Schröder R; Lappalainen P; Fürst DO; Carpén O
Hum Mol Genet; 2003 Jan; 12(2):189-203. PubMed ID: 12499399
[TBL] [Abstract][Full Text] [Related]
6. Beyond LGMD1A: myotilin is a component of central core lesions and nemaline rods.
Schröder R; Reimann J; Salmikangas P; Clemen CS; Hayashi YK; Nonaka I; Arahata K; Carpén O
Neuromuscul Disord; 2003 Aug; 13(6):451-5. PubMed ID: 12899871
[TBL] [Abstract][Full Text] [Related]
7. Developmental expression of myotilin, a gene mutated in limb-girdle muscular dystrophy type 1A.
Mologni L; Salmikangas P; Fougerousse F; Beckmann JS; Carpén O
Mech Dev; 2001 May; 103(1-2):121-5. PubMed ID: 11335118
[TBL] [Abstract][Full Text] [Related]
8. Myotilin overexpression enhances myopathology in the LGMD1A mouse model.
Garvey SM; Liu Y; Miller SE; Hauser MA
Muscle Nerve; 2008 May; 37(5):663-7. PubMed ID: 18335471
[TBL] [Abstract][Full Text] [Related]
9. Actin-organising properties of the muscular dystrophy protein myotilin.
von Nandelstadh P; Grönholm M; Moza M; Lamberg A; Savilahti H; Carpén O
Exp Cell Res; 2005 Oct; 310(1):131-9. PubMed ID: 16122733
[TBL] [Abstract][Full Text] [Related]
10. Characterization of mouse myotilin and its promoter.
Mologni L; Moza M; Lalowski MM; Carpén O
Biochem Biophys Res Commun; 2005 Apr; 329(3):1001-9. PubMed ID: 15752755
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mice expressing the myotilin T57I mutation unite the pathology associated with LGMD1A and MFM.
Garvey SM; Miller SE; Claflin DR; Faulkner JA; Hauser MA
Hum Mol Genet; 2006 Aug; 15(15):2348-62. PubMed ID: 16801328
[TBL] [Abstract][Full Text] [Related]
12. A novel mutation in the myotilin gene (MYOT) causes a severe form of limb girdle muscular dystrophy 1A (LGMD1A).
Reilich P; Krause S; Schramm N; Klutzny U; Bulst S; Zehetmayer B; Schneiderat P; Walter MC; Schoser B; Lochmüller H
J Neurol; 2011 Aug; 258(8):1437-44. PubMed ID: 21336781
[TBL] [Abstract][Full Text] [Related]
13. Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype.
Berciano J; Gallardo E; Domínguez-Perles R; Gallardo E; García A; García-Barredo R; Combarros O; Infante J; Illa I
J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):205-8. PubMed ID: 17698502
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy.
Herrmann R; Straub V; Blank M; Kutzick C; Franke N; Jacob EN; Lenard HG; Kröger S; Voit T
Hum Mol Genet; 2000 Sep; 9(15):2335-40. PubMed ID: 11001938
[TBL] [Abstract][Full Text] [Related]
15. Indications for a novel muscular dystrophy pathway. gamma-filamin, the muscle-specific filamin isoform, interacts with myotilin.
van der Ven PF; Wiesner S; Salmikangas P; Auerbach D; Himmel M; Kempa S; Hayess K; Pacholsky D; Taivainen A; Schröder R; Carpén O; Fürst DO
J Cell Biol; 2000 Oct; 151(2):235-48. PubMed ID: 11038172
[TBL] [Abstract][Full Text] [Related]
16. Myotilin: a prominent marker of myofibrillar remodelling.
Carlsson L; Yu JG; Moza M; Carpén O; Thornell LE
Neuromuscul Disord; 2007 Jan; 17(1):61-8. PubMed ID: 17056257
[TBL] [Abstract][Full Text] [Related]
17. The Z-disc proteins myotilin and FATZ-1 interact with each other and are connected to the sarcolemma via muscle-specific filamins.
Gontier Y; Taivainen A; Fontao L; Sonnenberg A; van der Flier A; Carpen O; Faulkner G; Borradori L
J Cell Sci; 2005 Aug; 118(Pt 16):3739-49. PubMed ID: 16076904
[TBL] [Abstract][Full Text] [Related]
18. [LGMD1A(myotilin deficiency)].
Sunada Y
Ryoikibetsu Shokogun Shirizu; 2001; (35):67-9. PubMed ID: 11555993
[No Abstract] [Full Text] [Related]
19. Different early pathogenesis in myotilinopathy compared to primary desminopathy.
Fischer D; Clemen CS; Olivé M; Ferrer I; Goudeau B; Roth U; Badorf P; Wattjes MP; Lutterbey G; Kral T; van der Ven PF; Fürst DO; Vicart P; Goldfarb LG; Moza M; Carpen O; Reichelt J; Schröder R
Neuromuscul Disord; 2006 Jun; 16(6):361-7. PubMed ID: 16684602
[TBL] [Abstract][Full Text] [Related]
20. Telethonin protein expression in neuromuscular disorders.
Vainzof M; Moreira ES; Suzuki OT; Faulkner G; Valle G; Beggs AH; Carpen O; Ribeiro AF; Zanoteli E; Gurgel-Gianneti J; Tsanaclis AM; Silva HC; Passos-Bueno MR; Zatz M
Biochim Biophys Acta; 2002 Oct; 1588(1):33-40. PubMed ID: 12379311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
